Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | MDGL | GRFS | ||
| Company | Cerevel Therapeutics Hldg Inc | Madrigal Pharmaceuticals Inc | Grifols S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.99 | 445.00 | 7.59 | ||
| High | 44.99 | 449.14 | 7.70 | ||
| Low | 44.96 | 437.05 | 7.57 | ||
| Latest | 44.96 | 445.04 | 7.60 | ||
| Change | +0.33 | -2.68 | -0.09 | ||
| % Change | +0.74% | -0.60% | -1.17% | ||
| Volume | 15,096,300 | 234,705 | 726,655 | ||
| 20-Day Average Volume | 2,839,210 | 312,875 | 935,548 | ||
| Previous Close | 44.63 | 447.72 | 7.69 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 438.83 | 8.31 | ||
| 20-Day Raw Stochastic | 99.49% | 56.88% | 4.80% | ||
| 20-Day Relative Strength | 68.05 | 45.18 | 33.43 | ||
| Weighted Alpha | +49.03 | +29.31 | -8.17 | ||
| Today's Opinion | 72% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 72% Buy | 24% Sell | 100% Sell | ||
| Last Month's Opinion | 8% Buy | 8% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | +0.42% since 03/17/26 | -5.24% since 03/17/26 | ||
| Low | 43.75 on 07/25/24 | 427.76 on 03/18/26 | 7.51 on 03/20/26 | ||
| High | 44.99 on 07/31/24 | 466.90 on 03/20/26 | 7.96 on 03/18/26 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | +1.15% since 02/24/26 | -16.21% since 02/24/26 | ||
| Low | 39.16 on 07/03/24 | 416.21 on 03/03/26 | 7.51 on 03/20/26 | ||
| High | 44.99 on 07/31/24 | 466.90 on 03/20/26 | 9.28 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | -26.17% since 12/24/25 | -15.84% since 12/24/25 | ||
| Low | 38.50 on 06/25/24 | 416.21 on 03/03/26 | 7.51 on 03/20/26 | ||
| High | 44.99 on 07/31/24 | 608.34 on 12/26/25 | 9.77 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +4.26% since 09/24/25 | -22.92% since 09/24/25 | ||
| Low | 38.50 on 06/25/24 | 393.61 on 10/29/25 | 7.51 on 03/20/26 | ||
| High | 44.99 on 07/31/24 | 615.00 on 12/24/25 | 10.23 on 10/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 10,270,697 | 5,287,336 | ||
| Shares Outstanding, K | 182,195 | 22,940 | 687,560 | ||
| Annual Sales | 0 | 958,400,000 | 8,512,650,000 | ||
| Annual Net Income | -432,840,000 | -288,280,000 | 565,700,000 | ||
| Last Quarter Sales | 0 | 321,080,000 | 2,304,030,000 | ||
| Last Quarter Net Income | -131,910,000 | -58,570,000 | 221,480,000 | ||
| 60-Month Beta | 1.40 | -0.97 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -2.57 on 02/19/26 | 0.19 on 07/28/25 | ||
| Latest Earnings Date | 08/07/24 | 05/07/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | 0.142 on 08/12/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 08/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||